PHOSPHORYLATION OF THE TAL1 ONCOPROTEIN BY THE EXTRACELLULAR-SIGNAL-REGULATED PROTEIN-KINASE ERK1

被引:76
作者
CHENG, JT
COBB, MH
BAER, R
机构
[1] UNIV TEXAS, SW MED CTR, DEPT MICROBIOL, 5323 HARRY HINES BLVD, DALLAS, TX 75235 USA
[2] UNIV TEXAS, SW MED CTR, DEPT PHARMACOL, DALLAS, TX 75235 USA
关键词
D O I
10.1128/MCB.13.2.801
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alteration of the TAL1 gene is the most common genetic lesion found in T-cell acute lymphoblastic leukemia. TALI encodes phosphoproteins, pp42TAL1 and pp22TAL1, that represent phosphorylated versions of the full-length (residues 1 to 331) and truncated (residues 176 to 331) TAL1 gene products, respectively. Both proteins contain the basic helix-loop-helix motif, a DNA-binding and protein dimerization motif common to several known transcriptional regulatory factors. We now report that serine residue 122 (S122) is a major phosphorylation site of pp42TAL1 in leukemic cell lines and transfected COS1 cells. In vivo phosphorylation of S122 is induced by epidermal growth factor with a rapid time course that parallels activation of the ERK/MAP2 protein kinases. Moreover, S122 is readily phosphorylated in vitro by the extracellular signal-regulated protein kinase ERK1. These data suggest that TAL1 residue S122 serves as an in vivo substrate for ERK/MAP2 kinases such as ERK1. Therefore, S122 phosphorylation may provide a mechanism whereby the properties of TAL1 polypeptides can be modulated by extracellular stimuli.
引用
收藏
页码:801 / 808
页数:8
相关论文
共 46 条
[1]  
ALVAREZ E, 1991, J BIOL CHEM, V266, P15277
[2]  
ANDERSSON S, 1989, J BIOL CHEM, V264, P8222
[3]  
BALL RL, 1990, J BIOL CHEM, V265, P12836
[4]   THE GENE SCL IS EXPRESSED DURING EARLY HEMATOPOIESIS AND ENCODES A DIFFERENTIATION-RELATED DNA-BINDING MOTIF [J].
BEGLEY, CG ;
APLAN, PD ;
DENNING, SM ;
HAYNES, BF ;
WALDMANN, TA ;
KIRSCH, IR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (24) :10128-10132
[5]   2 DISTINCT MECHANISMS FOR THE SCL GENE ACTIVATION IN THE T(I-14) TRANSLOCATION OF T-CELL LEUKEMIAS [J].
BERNARD, O ;
GUGLIELMI, P ;
JONVEAUX, P ;
CHERIF, D ;
GISSELBRECHT, S ;
MAUCHAUFFE, M ;
BERGER, R ;
LARSEN, CJ ;
MATHIEUMAHUL, D .
GENES CHROMOSOMES & CANCER, 1990, 1 (03) :194-208
[6]   A 3RD TAL-1 PROMOTER IS SPECIFICALLY USED IN HUMAN T-CELL LEUKEMIAS [J].
BERNARD, O ;
AZOGUI, O ;
LECOINTE, N ;
MUGNERET, F ;
BERGER, R ;
LARSEN, CJ ;
MATHIEUMAHUL, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (04) :919-925
[7]  
BERNARD O, 1991, ONCOGENE, V6, P1477
[8]   HA-RAS AUGMENTS C-JUN ACTIVITY AND STIMULATES PHOSPHORYLATION OF ITS ACTIVATION DOMAIN [J].
BINETRUY, B ;
SMEAL, T ;
KARIN, M .
NATURE, 1991, 351 (6322) :122-127
[9]  
BLENIS J, 1991, CANCER CELL-MON REV, V3, P445
[10]  
BOHMANN D, 1990, CANCER CELL-MON REV, V2, P337